prof. Sylvie Rottey (MD, PhD)

For the last twenty years, prof. dr. Rottey is involved in international high-level research towards novel therapeutic options for patients with various solid tumors As prof. dr. Rottey is leading phase I oncology clinical trials for more than a decade, she has worked and continues to work with different immunotherapies in development, antibody drug conjugates, T-cell therapies, biomarker based treatments,… .

Prof. dr. Rottey is promotor for the doctorate of:

• dr. Alexander Decruyenaere (MD) – co-investigator, doctoral fellow, 2022 - ongoing: 'The Real Deal Behind the Artificial Appeal: Inferential Utility of Tabulator Synthetic Data'
• dr. Daan De Maeseneer (MD) – co-investigator, doctoral fellow, 2020 – ongoing: 'Evaluating bladder cancer genetics as predictive and prognostic biomarkers'
• Lissa Eggermont – doctoral fellow, 2023 – ongoing: 'Urine N-glycosylation as biomarker for prostate cancer: optimalisation of preanalytic conditions and correlation to clinical parameters in the differential diagnosis of prostate cancer'
• dr. Michael Saerens (MD) – co-investigator, doctoral fellow, 2022 – ongoing: 'Tumor-associated macrophages in head and neck squamous cell carcinoma: association with CD8+ tumor-infiltrating T-lymphocytes and impact on survival'
• Li Shoabo – doctoral fellow, 2024 – ongoing: 'SSTR-2 expression on tumor-associated macrophages in solid malignancies – predictive and prognostic value in patients receiving immune-checkpoint inhibitors'
• Mathieu Spaas – doctoral fellow, 2020 – ongoing: 'Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumours'
• dr. Eufra Van Damme (MD) - doctoral fellow, 2021 – ongoing: 'Prediction of immunotherapy response and toxicity in melanoma, renal cell and lung cancer using transcriptome based systemic immune phenotyping'
   

• Medical doctor, Ghent University, 1993-2000
• Board certificate of internal medicine, 2002
• Medical Oncology, 2003
• PhD: Doctor in Medical Science, 99mTc-HYNIC Annexin-V for monitoring response to chemotherapy: methodology and feasibility studies, 2007
• Professor in Pharmacology, 2011
• Head of Drug Research Unit Ghent , 2015
• Head of Department of Medical Oncology, 2000
• MD in  clinical pharmacology and pharmaceutical medicine, 2024
   

• prof. Sylvie Rottey (MD, PhD) – principal investigator
   
• Team members of the medical staff department of Medical Oncology:
  •    dr. Alexander Decruyenaere (MD) – co-investigator, doctoral fellow
  •    prof. Hannelore Denys (MD, PhD) – principal investigator, co-investigator
  •    dr. Daan De Maeseneer (MD) – co-investigator, doctoral fellow
  •    dr. Elien De Mulder (MD) – co-investigator
  •    dr. Aglaja De Pauw (MD) – co-investigator
  •    dr. Ingeborg Hilderson (MD) – co-investigator
  •    dr. Justine Himpe (MD) – co-investigator
  •    dr. Celine Jacobs (MD) – principal investigator, co-investigator
  •    prof. Lore Lapeire (MD, PhD) – principal investigator, co-investigator
  •    dr. Eline Naert (MD) – principal investigator, co-investigator, doctoral fellow
  •    dr. Michael Saerens (MD) – principal investigator, co-investigator, doctoral fellow
  •    dr. Tijl Vermassen (PhD) – post-doctoral researcher
   
• Team D.R.U.G, investigators:
  •    dr. Brant Delafontaine (MD) – co-investigator 
  •    dr. Greet Schelfaut (MD) – co-investigator
  •    dr. Griet Van Lancker (MD) – co-investigator
  •    dr. Jasper Vogels (MD) – co-investigator
   
• Team D.R.U.G, teamlead:
  •    Elke Colman, teamlead Safepedrug Clinical Trial Unit
  •    Katrijn Criel, teamlead Drug Research Unit Ghent
  •    Adelheid Hollebosch, teamlead Drug Research Unit Ghent
  •    Carla Vandenabeele, teamlead Drug Research Unit Ghent
   

Find all publications of prof. Rottey via Ghent University Academic Bibliography or PubMed
 

• drug@uzgent
• sylvie.rottey@UGent.be or sylvie.rottey@uzgent.be
• D.R.U.G.: UZ Gent, C. Heymanslaan 10, Nobel, entrance 7, route 7030, 9000 Gent
• Medical Oncology Department: UZ Gent, C. Heymanslaan 10, entrance 50, route 554, 9000 Gent